Elizabeth Phillips Selected Research

Isoniazid (Ftivazide)

4/2024	Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-like Reactions During Treatment of Latent Tuberculosis Infection.
1/2016	Mechanism of isoniazid-induced hepatotoxicity: then and now.
8/2015	Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth Phillips Research Topics

Disease

35	Hypersensitivity (Allergy) 12/2023 - 03/2004
8	COVID-19 01/2023 - 12/2020
8	Infections 07/2021 - 07/2007
7	Chemical and Drug Induced Liver Injury 01/2023 - 01/2016
6	Anaphylaxis (Anaphylactic Shock) 03/2024 - 10/2014
6	Drug-Related Side Effects and Adverse Reactions 11/2023 - 01/2005
4	Drug Hypersensitivity (Drug Allergy) 11/2023 - 08/2007
4	Hepatitis 10/2023 - 01/2005
4	Drug Hypersensitivity Syndrome 12/2022 - 03/2004
4	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2017
4	Dengue (Dengue Fever) 12/2017 - 10/2016
3	Neoplasms (Cancer) 09/2019 - 11/2015
2	Latent Tuberculosis 04/2024 - 08/2015
2	Liver Failure 01/2023 - 01/2016
2	Disease Progression 11/2021 - 09/2019
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 11/2019 - 05/2017
2	Tetanus 01/2018 - 01/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2017 - 01/2005
2	HIV Infections (HIV Infection) 01/2017 - 09/2009
2	Tuberculosis (Tuberculoses) 01/2016 - 08/2015
2	Hepatitis C 02/2008 - 07/2007
1	Chronic Hepatitis (Chronic Active Hepatitis) 10/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Severe Acute Respiratory Syndrome 01/2023
1	Obesity 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Necrosis 01/2023
1	red meat allergy 10/2022
1	Glioma (Gliomas) 08/2022
1	Astrocytoma (Pilocytic Astrocytoma) 08/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Stroke (Strokes) 01/2022
1	Atherosclerosis 01/2022
1	Whooping Cough (Pertussis) 11/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Hemolytic Anemia 01/2021
1	Yellow Fever 11/2020

Drug/Important Bio-Agent (IBA)

16	abacavir (Ziagen)FDA Link 01/2015 - 03/2004
12	HLA-B Antigens (HLA-B)IBA 01/2021 - 03/2004
8	AntigensIBA 01/2023 - 09/2004
8	EpitopesIBA 01/2022 - 01/2017
6	Penicillins (Penicillin)FDA Link 12/2023 - 05/2015
6	HLA-B57 antigenIBA 11/2019 - 01/2014
6	Nevirapine (Viramune)FDA Link 01/2015 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 12/2013
5	VaccinesIBA 01/2022 - 01/2017
5	Peptides (Polypeptides)IBA 12/2017 - 06/2012
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 04/2008
4	SynucleinsIBA 11/2021 - 01/2017
3	Isoniazid (Ftivazide)FDA LinkGeneric 04/2024 - 08/2015
3	Cephalosporins (Cephalosporin Antibiotics)IBA 03/2024 - 09/2019
3	Dyphylline (Diprophylline)FDA Link 01/2023 - 09/2019
3	mRNA VaccinesIBA 01/2021 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2017
3	Carbamazepine (Tegretol)FDA LinkGeneric 11/2019 - 03/2014
3	HLA-DRB1 Chains (HLA DRB1)IBA 10/2016 - 01/2005
2	AntibodiesIBA 04/2024 - 01/2016
2	rifapentine (Priftin)FDA Link 04/2024 - 08/2015
2	EnzymesIBA 10/2023 - 09/2019
2	InterferonsIBA 01/2023 - 08/2022
2	ChemokinesIBA 01/2023 - 08/2022
2	CytokinesIBA 01/2022 - 01/2008
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 03/2004
2	HLA-A Antigens (HLA-A)IBA 01/2021 - 12/2018
2	Allopurinol (Remid)FDA LinkGeneric 01/2021 - 01/2015
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2018 - 01/2017
2	Attenuated VaccinesIBA 12/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2008
1	SulfonamidesIBA 11/2023
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 01/2023
1	Vancomycin FDA LinkGeneric 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 10/2022
1	Choline (Choline Chloride)IBA 08/2022
1	Inositol (Myoinositol)IBA 08/2022
1	alpha-hydroxyglutarateIBA 08/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	AutoantigensIBA 11/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	carfilzomibIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Herpes Zoster VaccineIBA 11/2020
1	HLA-A31 antigenIBA 11/2019

Therapy/Procedure

4	Therapeutics 09/2019 - 07/2007
3	Drug Therapy (Chemotherapy) 01/2023 - 10/2017
2	Liver Transplantation 01/2023 - 12/2018
2	Precision Medicine 11/2015 - 08/2007
1	Immunomodulation 10/2023
1	Obesity Management 01/2023
1	Duration of Therapy 01/2022
1	Patient Transfer (Patient Dumping) 01/2022
1	Secondary Prevention 01/2022
1	Premedication 01/2021
1	Injections 01/2021